Home 2019-02-20T12:13:45+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Our new #openscience drug companies (e.g. @M4KPharma) are owned entirely by Agora Open Science Trust, a charity we formed. Agora’s mandates are to price any new medicine affordably, and to give away all profits. My inspiration was @NewmansOwnFdn.

@aledmedwards @M4KPharma @thesgconline @BrainTumourOrg @wellcometrust We are so proud to partner with this amazing organization and contribute to the important work being done. Thank you for your commitment, Aled!

The @M4KPharma project to invent an affordable ALK2 drug for #DIPG marches on. Going great. And @CRiverLabs continues to contribute/donate their skills and ideas. An awesome partner. #openscience @thesgconline @BrainTumourOrg @wellcometrust

yes #openscience is good for patients and good for business! @aledmedwards @M4KPharma @IP_policy @SciChefQC @Serge_Marchand @ChiefSciCan @CemmaM @Neuronologist1 @bsw5020 https://t.co/EtYIxXs1T1

Looking probable we won't make it 58,508 signatures still needed. Twitterverse do please prove me wrong! Not sure how this is not important ENOUGH? no matter what, it's still gone much further than before TY 💗#DIPG #ResearchMatters https://t.co/tTfvI6URmo

Load More...

Latest Blog Posts